Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/295015 
Year of Publication: 
2022
Citation: 
[Journal:] Junior Management Science (JUMS) [ISSN:] 2942-1861 [Volume:] 7 [Issue:] 4 [Year:] 2022 [Pages:] 1164-1192
Publisher: 
Junior Management Science e. V., Planegg
Abstract: 
The relationship between mergers and acquisitions (M&A) and innovation in the healthcare sector (pharmaceuticals, biotechnology, medical devices, and life sciences) is investigated using a new self-generated dataset of 41 firms. Patents are used as proxy for innovation performance of acquiring firms. This work can also be seen as an extended replication study of Ahuja and Katila (2001) and Cloodt et al. (2006). The extension comprises of newly added variables relatedness of acquirer knowledge and acquisition experience. The findings are consistent with previous research. Non-technological M&A appear to have a negative impact on the acquiring firm's innovation performance. The absolute size of acquired knowledge has a small positive effect. The relative size of acquired knowledge has a negative effect on the acquiring firm's innovation performance. The relatedness of the target knowledge base has a curvilinear impact on innovative performance. The relatedness of acquirer knowledge has a negative effect on innovation performance. Finally, the effect of previous acquisition experience is ambiguous. The findings of this study indicate that the firms' innovation performance can benefit from M&A by carefully selecting targets that provide the appropriate amount of "innovative" input.
Subjects: 
Mergers & Acquisitions
Innovation
Innovation Performance
Patents
Knowledge based view
Persistent Identifier of the first edition: 
Creative Commons License: 
cc-by Logo
Document Type: 
Article
Appears in Collections:

Files in This Item:
File
Size
700.33 kB
3.93 MB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.